Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone Palmitate in Schizophrenia
NCT01860781Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2011
- Primary completion
- Dec 2015
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of paliperidone palmitate in schizophrenia, sponsored by Seoul National University Hospital. Started Aug 2011; status: completed.
02
Drugs
paliperidone palmitate
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01860781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01860781.